These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 11224390)
21. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801. Seillier A; Giuffrida A Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985 [TBL] [Abstract][Full Text] [Related]
22. The effects of chronic administration of quetiapine on the phencyclidine-induced reference memory impairment and decrease of Bcl-XL/Bax ratio in the posterior cingulate cortex in rats. He J; Xu H; Yang Y; Rajakumar D; Li X; Li XM Behav Brain Res; 2006 Apr; 168(2):236-42. PubMed ID: 16360889 [TBL] [Abstract][Full Text] [Related]
23. Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Sams-Dodd F Rev Neurosci; 1999; 10(1):59-90. PubMed ID: 10356992 [TBL] [Abstract][Full Text] [Related]
24. Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs. Sun T; Hu G; Li M Eur J Pharmacol; 2009 Jan; 602(2-3):334-42. PubMed ID: 19059234 [TBL] [Abstract][Full Text] [Related]
25. Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat. Liu J; Suzuki T; Seki T; Namba T; Tanimura A; Arai H Synapse; 2006 Jul; 60(1):56-68. PubMed ID: 16596623 [TBL] [Abstract][Full Text] [Related]
26. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Mouri A; Noda Y; Enomoto T; Nabeshima T Neurochem Int; 2007; 51(2-4):173-84. PubMed ID: 17669558 [TBL] [Abstract][Full Text] [Related]
27. Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats. Schwabe K; Klein S; Koch M Behav Brain Res; 2006 Mar; 168(1):150-60. PubMed ID: 16387372 [TBL] [Abstract][Full Text] [Related]
28. Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study. Kalinichev M; Robbins MJ; Hartfield EM; Maycox PR; Moore SH; Savage KM; Austin NE; Jones DN Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):414-22. PubMed ID: 17945407 [TBL] [Abstract][Full Text] [Related]
29. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR. Olszewski RT; Bukhari N; Zhou J; Kozikowski AP; Wroblewski JT; Shamimi-Noori S; Wroblewska B; Bzdega T; Vicini S; Barton FB; Neale JH J Neurochem; 2004 May; 89(4):876-85. PubMed ID: 15140187 [TBL] [Abstract][Full Text] [Related]
30. (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Rung JP; Carlsson A; Rydén Markinhuhta K; Carlsson ML Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):827-32. PubMed ID: 15916843 [TBL] [Abstract][Full Text] [Related]
31. Selective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs. Paterson GJ; Ohashi Y; Reynolds GP; Pratt JA; Morris BJ J Psychopharmacol; 2006 Sep; 20(5):636-42. PubMed ID: 16478754 [TBL] [Abstract][Full Text] [Related]
32. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. Abdul-Monim Z; Neill JC; Reynolds GP J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300 [TBL] [Abstract][Full Text] [Related]
33. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders]. Baghdadli A; Gonnier V; Aussilloux C Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786 [TBL] [Abstract][Full Text] [Related]
34. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Gaisler-Salomon I; Weiner I Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023 [TBL] [Abstract][Full Text] [Related]
35. Baseline temperature in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration. Radonjić NV; Petronijević ND; Vucković SM; Prostran MS; Nesić ZI; Todorović VR; Paunović VR Physiol Behav; 2008 Feb; 93(3):437-43. PubMed ID: 17996259 [TBL] [Abstract][Full Text] [Related]
36. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine. Nabeshima T; Mouri A; Murai R; Noda Y Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514 [TBL] [Abstract][Full Text] [Related]
37. Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis. Enomoto T; Noda Y; Nabeshima T Methods Find Exp Clin Pharmacol; 2007 May; 29(4):291-301. PubMed ID: 17609743 [TBL] [Abstract][Full Text] [Related]
38. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Javitt DC Hillside J Clin Psychiatry; 1987; 9(1):12-35. PubMed ID: 2820854 [TBL] [Abstract][Full Text] [Related]
39. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol. Hashimoto K; Fujita Y; Shimizu E; Iyo M Eur J Pharmacol; 2005 Sep; 519(1-2):114-7. PubMed ID: 16099452 [TBL] [Abstract][Full Text] [Related]